Starting fro'/>
机译:喹唑啉/嘧啶-2,4(1℃,3℃,3℃/酮) - 作为大麻素受体的激动剂2
College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China;
CAS Key Laboratory of Receptor Research National Center for Drug Screening Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 P. R. China;
College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China;
College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China;
CAS Key Laboratory of Receptor Research National Center for Drug Screening Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 P. R. China;
College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China;
Cannabinoid receptors; CB2 agonist; molecular modeling; structure?activity relationship;
机译:喹唑啉/嘧啶-2,4(1℃,3℃,3℃/酮) - 作为大麻素受体的激动剂2
机译:大麻素2,4(1H,3H)-二酮作为大麻素2型受体的强效和选择性配体的开发
机译:1,3-二甲基-2,4-二氧代-1H,2H,3H,4H-喹唑啉和1,5-二氢-1,3-二甲基-5-硝基甲基-2H-吡喃并[4,3-d]嘧啶-2,4(3H)-二酮
机译:含1H-茚-1,3(2H)-二酮和嘧啶-2,4,6(1H)的玻璃状2-(1-苄基-2-苯乙烯基-6-甲基吡啶-4(1-H)-亚烷基)片段具有发光和放大的自发发射特性的3H,5H)-三酮衍生物
机译:大麻素受体2激动剂通过抑制基质金属蛋白酶9减少神经炎症中的免疫细胞迁移。
机译:1-{[((2,3-dihydro-1H-inden-2-yl)oxy]甲基]喹唑啉-2,4(1H,3H)-二酮
机译:喹唑啉/嘧啶-2,4(1H,3H)脱酮作为大麻素受体2型的激动剂